Clear answers for
careful decisions.

We listen. You tell us what hurts, what you have already tried, and what you hope to get back to. We explain whether an in-clinic evaluation appears worth your time and money—and if it does not, we will say so. Nothing is diagnosed, prescribed, or sold during the initial phone consultation.

You meet with a provider at our Sandy clinic for a history and physical exam, review of available imaging and records, and a clear discussion of what may or may not be reasonable to attempt. Blood work may be ordered when appropriate. If you begin a care plan, the $197 is credited toward it.

No. You can book the free consultation yourself.

Plan for about an hour. It is a provider visit—not a sales call—and we do not want the evaluation to feel rushed.

Bring an accurate medication list and any relevant records, imaging or imaging reports, laboratory results, prior recommendations, and questions you want answered.

That is decided case by case. We can use recent imaging or blood work when appropriate. If something additional is needed, your provider will explain what to obtain and why rather than guess.

Yes, and we encourage it. Two people often hear a plan better than one, and it can be easier to ask difficult questions with someone you trust in the room.

No. The free screening can be completed by phone, but candidacy requires an in-person evaluation and physical examination at our Sandy clinic.

Free consultations are scheduled Monday through Friday, 9:00 a.m. to 4:00 p.m. You can book through our website or call 385-472-1998 for assistance.

Candidacy is determined individually by a provider after examining you and considering your health history, goals, risks, and available alternatives. It is not decided by a form, quiz, website, or phone call, and not everyone qualifies.

Examples include an active infection in or near the area being considered, an active malignancy near the treatment site, pregnancy or breastfeeding, or a clear indication that surgical evaluation is the more appropriate next step.

Not automatically. Blood thinners are held or adjusted only in coordination with the clinician who prescribed them—never on Soma’s direction alone.

Yes. If a corticosteroid was injected into the same area within the previous four weeks, we wait. Anti-inflammatory medications such as NSAIDs are generally paused for about five days beforehand under clinician guidance.

Usually, yes, although an active malignancy near the proposed treatment site is an exception. These conditions affect what may be reasonable and are reasons to coordinate with the clinicians already caring for you.

Tell us during the first call. Hardware changes what can be reached and what is sensible to attempt. In some cases, the honest answer may be that Soma has nothing appropriate to offer.

Yes, and we prefer to when appropriate. Soma is an addition to your care—not a replacement for it—and, with your authorization, we can request or send records so decisions are made with better context.

Most people describe pressure and an ache rather than sharp pain. Local anesthetic is used where appropriate, and soreness for a few days afterward is common.

That depends on the area being addressed and what the examination shows. Plans are often a series rather than a single injection, and another series is generally not considered before four to six months. Your schedule is provided in writing before you begin.

It means the clinician uses live imaging to guide needle placement rather than relying on touch alone. It is used when appropriate for the intended target.

No result is guaranteed. We reassess function at approximately three months, and if you are not responding, we will tell you rather than automatically recommending another round. Services paid for but not received are refundable in full.

No. You receive the recommended plan and price in writing and may take the time you need to make a decision.

Any injection carries risks, including pain, swelling or bruising at the site, bleeding, infection, injury to a nerve or blood vessel, allergic reaction, and the possibility of no benefit. These preparations are not FDA-approved for these uses. You receive the complete risk information in writing and sign informed consent before anything is administered.

You receive a direct number for your treating provider rather than being routed through a call center. For a serious allergic reaction or other emergency, call 911 first and then contact us. We have not seen a serious allergic reaction occur, but you should understand the response plan before you need it.

No. Individual response varies. Soma does not guarantee candidacy, improvement, tissue regrowth, avoidance of surgery, or any particular outcome.

Follow-up and functional reassessment are scheduled according to your written care plan so progress, questions, and the next appropriate step can be reviewed.

Soma uses different types of preparations. Exosome preparations are cell-free signaling vesicles and contain no cells. Extracellular-matrix allografts are perinatal tissue preparations that contain cell populations, including mesenchymal cells. Your provider will tell you exactly which material is proposed. When Utah’s stem-cell requirements apply, you will receive the required notice and written consent.

When Soma refers to stem cells, we mean human mesenchymal stem cells from umbilical-cord and placental tissue donated after healthy, full-term Cesarean births in Utah. The material is processed and screened by an accredited U.S. tissue establishment and is permitted for use under applicable Utah law. It is not FDA-approved to treat joint conditions.

They are donated perinatal tissue preparations containing cell populations and naturally occurring growth factors and cytokines. They are not embryonic stem cells, are not sourced from aborted fetal tissue, are not taken from your own body, and are not grown or multiplied in a laboratory.

The material comes from perinatal tissue donated after delivery with consent and is processed by a U.S. tissue establishment. Federal tissue rules place donor-eligibility screening and infectious-disease testing with that establishment. Our supplier reports 14-day sterility testing for each batch.

Yes, and you should ask. Utah law requires the provider to obtain the supplier’s post-thaw viability report for the specific lot before use. You may ask to review that report and the product labeling.

PRP—platelet-rich plasma—is prepared from your own blood, drawn and processed at the time of care. Soma’s perinatal tissue materials are donated and prepared by an outside tissue establishment. They are different categories with different preparation methods and regulatory status.

No. Soma does not claim that these preparations regrow, rebuild, or replace tissue, or that they treat or cure disease. The goal may be a change in symptoms or function, and that change may not occur.

No. Stem-cell and regenerative medicine therapies are not FDA-approved for orthopedic conditions or general use, and the preparations discussed by Soma are investigational for these uses.

Utah Code § 58-1-512 allows a licensed clinician to offer non-FDA-approved stem-cell therapy for orthopedics, wound care, or pain management when specified conditions are met. These include required advertising language, documented informed consent, supplier requirements, and lot-level testing. Utah law does not make a product FDA-approved.

No. Facility registration, product listing, or a clinical-trial listing is not FDA approval for a particular product or use.

Soma provides the Utah-required notice explaining that the practitioner performs one or more stem-cell therapies that have not been approved by the FDA and encouraging consultation with your primary care provider.

The FDA publishes patient and consumer information about regenerative medicine therapies, and Utah Code § 58-1-512 describes the state requirements. Your clinician should also explain the regulatory status relevant to anything proposed for you.

The phone consultation is free. The in-clinic provider consultation is $197 and is credited toward your care plan if you proceed.

Single-joint care starts at $5,100 for a 2 mL treatment, although some patients may require only 1 mL. Because plans depend on the area, examination findings, and goals, your exact price is provided in writing before anything is scheduled.

No. These are elective, self-pay services and are not covered by insurance or Medicare. Soma provides the anticipated cost before care begins, so you will not receive a surprise bill from us afterward.

Yes. Soma accepts HSA and FSA cards. Eligibility for a particular service is ultimately determined by your plan administrator, so retain your written treatment plan and receipt.

Yes. Patient financing is available through Cherry for those who qualify. Approval, terms, and interest are established by the lender, and monthly payments cannot be quoted before approval.

Any services that are unused or have not yet been rendered are 100% refundable.

Yes. Health information is handled in accordance with applicable privacy and HIPAA requirements. It is not sold or used for advertising. Our Privacy Policy explains what the website collects and why.

Please do not send sensitive medical information through the public chat. Clinical information is collected through an appropriate intake process.

The current messaging program is limited to inquiry responses and appointment or service communications, as described in our Privacy Policy and SMS Terms.

We would rather publish nothing than publish something we cannot substantiate. Testimonials require a valid written patient release, and one person’s experience does not predict another’s. When testimonials are published, they will be authentic, authorized, and clearly presented as individual experiences—not promises.

Your care instructions include the appropriate contact information. When clinical follow-up is needed, you can reach the treating team directly rather than relying on the public website chat.